Resistance of Targeted Therapies Excluding Antibodies for Lymphomas, Paperback

This paperback book provides a comprehensive overview of the resistance mechanisms that can develop in response to targeted therapies, excluding antibodies, for the treatment of lymphomas. The book covers various types of targeted therapies that are commonly used in the management of lymphomas, such as small molecule inhibitors, kinase inhibitors, and epigenetic modulators. It delves into the molecular mechanisms underlying resistance to these therapies and discusses strategies to overcome or prevent resistance. The authors also highlight recent advances in the field and discuss potential future directions for the development of more effective targeted therapies for lymphomas. Overall, this book serves as a valuable resource for researchers, clinicians, and students interested in understanding the challenges of resistance to targeted therapies in the treatment of lymphomas.